5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment.

Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of illness and treatment suitability. In this pilot, we examined nine patients with amnestic mild cognitive impairment (MCI) and 10 age and edu...

全面介紹

書目詳細資料
Main Authors: Terrière, E, Dempsey, M, Herrmann, L, Tierney, K, Lonie, J, O'Carroll, R, Pimlott, S, Wyper, D, Herholz, K, Ebmeier, K
格式: Journal article
語言:English
出版: 2010

相似書籍